Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vets call for improved global access to veterinary medicines
The statement forms part of the organisation’s efforts to secure equal access to vital veterinary medicines.

Position Statement designed to raise awareness of problems around regulation

Eleven veterinary associations, including the WSAVA and the Federation of Veterinarians of Europe, have signed a Position Statement calling for improved global access to veterinary medicines.


Initiated by the WSAVA, the statement forms part of the organisation’s efforts to secure equal access to vital veterinary medicines for companion animal practitioners around the world.


Regulatory issues in regions such as Eastern Europe, Africa and Asia have restricted access to veterinary medicines for some time and limit the effort of many veterinary surgeons to provide optimal care for their patients. Even essential medicines - such as those used to manage pain - are often difficult to access, causing immense and unnecessary suffering. 


Dr Walt Ingwersen, WSAVA past president, said: “Difficulty in accessing therapeutics to treat patients is a critical issue for companion animal veterinarians in many parts of the world. It causes huge frustration and means that many, if not most, companion animals globally do not receive optimum care.

"It’s a situation which requires urgent change and, working in partnership with our colleagues across the veterinary sector, we are focused on bringing this about.”

To spearhead its work in this area, the WSAVA recently formed a Therapeutics Guidelines Group (TGG). Its new Position Statement is designed to raise awareness of the problems around regulation and to call on governments and regulatory bodies to act.

he Statement has been endorsed by:


  • The World Veterinary Association
  • HealthforAnimals
  • The Federation of European Companion Animal Veterinary Associations
  • The Commonwealth Veterinary Association
  • The Federación Iberoamericana de Asociaciones Veterinarias de Animales de Compañía
  • The Federation of Asian Small Animal Veterinary Associations
  • The Federation of Veterinarians of Europe
  • The Federation of Asian Veterinary Associations.
  • The Fédération des Associations Francophones Vétérinaires pour Animaux de Compagnie
  • The Caribbean Veterinary Medical Association


Dr Ingwersen continued: “While a number of issues impact the supply of veterinary medicines, duplication of the regulatory medicines approval process in various regions of the world is one of the biggest and the focus of our joint Position Statement on regulatory convergence.

"The WSAVA Therapeutics Guidelines Group has been working hard on the issue of access to and availability of veterinary medicines and will shortly be announcing the first of a set of practical tools to support veterinarians and their associations to lobby their own governments and regulatory bodies." 


He continued: "To support them, we, as a global veterinary community, will continue to demand change at a global level and our Position Statements are proving effective in increasing understanding and prompting action.

He added: “We thank our colleagues in other veterinary associations for standing with us and we will continue to collaborate closely to ensure that all veterinarians have access to the drugs they need to treat their patients.”

 

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.